Drugs
-
Bupropion hydrochloride (marketed as Wellbutrin, Zyban, and generics) Information
Bupropion hydrochloride is marketed under the following names:
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Zyban
bupropion hydrochloride
Adverse reactions or quality problems experienced with the use of this Product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
-
Related Information
Public Health Advisory: FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban
7/1/2009Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics)
7/1/2009- Podcast: FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban
7/7/2009 Antidepressant Use in Children, Adolescents, and Adults
5/2007- Information for Healthcare Professionals: Bupropion hydrochloride (marketed as the antidepressant Wellbutrin)
7/8/2005 Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications
6/30/2005Medication Guide for Antidepressant Drugs (PDF - 28KB)
-
-
Labeling and Regulatory History from Drugs@FDA
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-